Bristol-Myers to buy Medarex for $16 a share cash
July 22, 2009 at 19:54 PM EDT
Bristol-Myers has signed a deal to buy biopharmaceutical firm Medarex for almost double its Wednesday close, with an aggregate purchase price of about $2.4 billion in cash.